Halozyme (HALO) Debt/EBITDA US GAAP (year values)

2022 2022 2023 2024 2025   LTM ?
Debt/EBITDA 3.62 3.62 2.57 1.39 -0.16   -0.11
Changes by years, y/y, % +591% 0% -29% -46% -111%    

Halozyme. Debt/EBITDA

Halozyme. Debt/EBITDA, changes, %

Halozyme (HALO) Debt/EBITDA US GAAP (quarter values)

2025Q1 2025Q2 2025Q3 2025Q4 2026Q1   LTM ?
Debt/EBITDA 1.10 1.23 0.98 -0.16 -0.11   -0.11
Changes by years, y/y, % -48% -35% -33% -111% -110%    
Changes by quarters, q/q, % -22% +13% -21% -116% -28%    

Halozyme. Debt/EBITDA

Halozyme. Debt/EBITDA, changes, y/y, %

Halozyme. Debt/EBITDA, changes, q/q, %